The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2024

Filed:

Oct. 04, 2022
Applicant:

University of Miyazaki, Miyazaki, JP;

Inventors:

Kazuo Kitamura, Miyazaki, JP;

Motoo Yamasaki, Miyazaki, JP;

Assignee:

UNIVERSITY OF MIYAZAKI, Miyazaki, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/575 (2006.01); A61K 38/22 (2006.01); A61K 47/60 (2017.01); A61P 9/08 (2006.01); A61P 9/12 (2006.01); A61P 29/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/60 (2017.08); A61K 38/22 (2013.01); A61P 9/08 (2018.01); A61P 9/12 (2018.01); A61P 29/00 (2018.01); C07K 14/575 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention provides a novel adrenomedullin derivative sustainable for a long period which is capable of substantially suppressing unwanted side effects while maintaining pharmacological effects of adrenomedullin. In an exemplary embodiment, the invention relates to a compound represented by formula (I): A-CH—B (I) [wherein A is a modifying group comprising one or more polyethylene glycol groups, and B is a peptide moiety derived from adrenomedullin or a modified form thereof with adrenomedullin activity, wherein the peptide moiety B is linked to the other moieties through a covalent bond of the nitrogen atom of the N-terminal α-amino group of the peptide moiety B to the carbon atom of the methylene group] or a salt thereof, or a hydrate thereof.


Find Patent Forward Citations

Loading…